- NCT00000231
Buprenorphine Detoxification With Two Types of Treatment. BBD IV - 13
Phase 2Completed - NCT00000239
Buprenorphine Pharmacology Related to Addiction Treatment - 21
Phase 2Completed - NCT00000240
Combined Buprenorphine and Behavioral Treatment With and Without Contingent Reinforcement on Opioid and Cocaine Abstinence. - 22
Phase 2Completed - NCT00000230
Buprenorphine Detoxification With Two Types of Treatment. BBD III - 12
Phase 2Completed - NCT00000241
Flupenthixol Decanoate in Methamphetamine Smoking - 1
Phase 2Completed - NCT00000242
Carbamazepine Treatment of Cocaine Dependence - 1
Phase 2Completed - NCT00000229
Buprenorphine Detox With Two Types of Treatment. BBD II - 11
Phase 2Completed - NCT00000243
Effects of Buprenorphine/Naloxone in Treating Opioid Dependent Individuals Who Are Maintained on Methadone
Not ApplicableTerminated - NCT00000244
Effects of Dynorphin 1-13 on Heroin Addiction - 1
Phase 2Completed - NCT00000228
Buprenorphine Detox With Two Types of Treatment. BBD I - 10
Phase 2Completed - NCT00000227
Alternate-Day Buprenorphine Administration. Phase VIII - 9
Phase 2Completed - NCT00000226
Alternate-Day Buprenorphine Administration. Phase VII - 8
Phase 2Completed - NCT00000245
Evaluation of a Desipramine Ceiling in Cocaine Abuse - 1
Phase 2Completed - NCT00000246
Rapid Benzodiazepine Detoxification Using Flumazenil - 1
Phase 2Completed - NCT00000225
Alternate-Day Buprenorphine Administration. Phase VI - 7
Phase 2Completed - NCT00000248
Dose Response Trial of Pergolide for Cocaine Dependence - 1
Phase 3Completed - NCT00000224
Alternate-Day Buprenorphine. Phase V - 6
Phase 1Completed - NCT00000249
Effects of Subanesthetic Concentrations of Nitrous Oxide - 1
Phase 2Completed - NCT00000250
Cold Water Immersion Modulates Reinforcing Effects of Nitrous Oxide - 2
Phase 2Completed - NCT00000251
Effects of Subanesthetic Concentrations of Isoflurane/Nitrous Oxide - 3
Phase 2Completed - NCT00000223
Alternate-Day Buprenorphine Administration. Phase IV - 5
Phase 2Completed - NCT00000222
Alternate-Day Buprenorphine Administration. Phase II - 4
Phase 1Completed - NCT00000221
Alternate-Day Buprenorphine Administration. Phase I - 3
Phase 1Completed - NCT00000252
Lack of Acute Tolerance Development to Effects of Nitrous Oxide - 4
Phase 2Completed - NCT00000220
Gradual Vs. Rapid Buprenorphine Detoxification - 2
Phase 1Completed - NCT00000253
Effects of Nitrous Oxide: A Dose-Response Analysis - 5
Not ApplicableCompleted - NCT00000256
Reinforcing Effects of Brief Exposures to Nitrous Oxide - 8
Not ApplicableCompleted - NCT00000219
Buprenorphine Dose Alteration Study - 1
Phase 1Completed - NCT00000257
Effects of Alcohol History on Effects of Nitrous Oxide - 9
Not ApplicableCompleted - NCT00000258
Role of Instructions in Nitrous Oxide Effects and Choice - 10
Not ApplicableCompleted - NCT00000218
Pharmacotherapy and Intensive Treatment - 2
Phase 4Completed - NCT00000217
Pharmacotherapy and Intensive Treatment of Drug Abuse - 1
Phase 2Completed - NCT00000263
Effects of Combined Alcohol and Nitrous Oxide Intake - 15
Not ApplicableCompleted - NCT00000216
Buprenorphine Maintenance for Cocaine Abusing Opioid Addicts - 1
Phase 3Completed - NCT00000264
Subjective/Psychomotor/ Effects of Combined Alcohol & Nitrous Oxide - 16
Not ApplicableCompleted - NCT00000265
Subjective Effects of Nitrous Oxide in Dental Patients - 17
Completed - NCT00000266
Flupenthixol Treatment in Schizophrenic Cocaine Abusers - 1
Phase 2Completed - NCT00000215
IV Cocaine Abuse: A Laboratory Model - 4
Phase 2Completed - NCT00000214
IV Cocaine Abuse: A Laboratory Model - 3
Phase 2Completed - NCT00000213
IV Cocaine Abuse: A Laboratory Model - 2
Phase 2Completed - NCT00000212
IV Cocaine Abuse: A Laboratory Model - 1
Phase 2Completed - NCT00000267
Risperidone Treatment in Dually-Diagnosed Individuals - 2
Phase 2Completed - NCT00000211
Treatment Efficacy for Drug Abuse and AIDS Prevention - 2
Phase 2Completed - NCT00000268
Cocaine Abuse and Attention Deficit Disorder - 3
Not ApplicableCompleted - NCT00000269
Pergolide Treatment for Substance Abusers - 4
Phase 2Completed - NCT00000331
Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment II-3 - 6
Phase 2Withdrawn - NCT00000259
Sevoflurane vs Nitrous Oxide Inhalation at Subanesthetic Concentrations - 11
Not ApplicableCompleted - NCT00000262
Effects of Combined Sevoflurane and Nitrous Oxide Inhalation - 14
Not ApplicableCompleted - NCT00000322
Tyrosine for Methamphetamine Dependence - 1
Phase 2Completed - NCT00000317
Early Phase II Trials for Cocaine Medication Development - 1
Phase 2Completed - NCT00000260
Effects of Behavioral Contingencies on Effects of Nitrous Oxide - 12
Not ApplicableCompleted - NCT00004639
Cleft Palate Surgery and Speech Development
Phase 2Completed - NCT00004640
"Clinical Trials to Enhance Elders' Oral Health" ("TEETH")
Phase 3Completed